ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $322 | -24.1% | 48 | 0.0% | 0.00% | – |
| Q1 2023 | $424 | +15.5% | 48 | 0.0% | 0.00% | – |
| Q4 2022 | $367 | -63.3% | 48 | -73.8% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 183 | -3.2% | 0.00% | – |
| Q2 2022 | $2,000 | -75.0% | 189 | -65.3% | 0.00% | -100.0% |
| Q1 2022 | $8,000 | -11.1% | 544 | +74.9% | 0.00% | -50.0% |
| Q4 2021 | $9,000 | +50.0% | 311 | +75.7% | 0.00% | +100.0% |
| Q3 2021 | $6,000 | +50.0% | 177 | +88.3% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | -66.7% | 94 | -50.5% | 0.00% | 0.0% |
| Q4 2020 | $12,000 | +200.0% | 190 | +134.6% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | +300.0% | 81 | +179.3% | 0.00% | – |
| Q2 2020 | $1,000 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |